Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications Thyroid cancer 7 Mar Written by Aleks Cancers 14 (2) 280.Jacquemin V., Antoine M., Dom G., Detours V., Maenhaut C., Dumont J.E. (2022) Aleks Previous Previous Zebrafish Galectin 3 binding protein is the target antigen of the microglial 4C4 monoclonal antibody Next Next Microglia states and nomenclature: A field at its crossroads
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications Thyroid cancer 7 Mar Written by Aleks Cancers 14 (2) 280.Jacquemin V., Antoine M., Dom G., Detours V., Maenhaut C., Dumont J.E. (2022) Aleks
